Headlines On Deadline …

Death rates after heart bypass surgery dropped 43 percent between 2000 and 2006, according to a recent Agency for Healthcare Research and Quality “News and Numbers” report. The proportion of patients who died in the hospital after undergoing the procedure fell from 42 per 1,000 admissions to 24 per 1,000. Rural hospitals reported the greatest improvement (92 percent), although their death rate of 38 deaths per 1,000 admissions was still higher than for other hospitals…. California regulators approved WellPoint’s plan to raise rates for individual health insurance policies by an average of 14 percent. WellPoint’s initial bid to increase the rate to 25 percent for 600,000 members drew heavy criticism earlier this year. The company, which is the largest U.S. health insurer by membership, says it intends to put the new rates into effect on Oct. 1…. The National Association of Insurance Commissioners voted to approve a guideline that would require large-group insurance plans to spend at least 85 percent of premiums collected on medical expenses, as opposed to administrative expenses. Small-group plans must spend 80 percent on medical expenses. The industry criticized the NAIC for adopting “a narrow category for what health plans count as medical care and quality improvements when calculating medical loss ratios.”

Meetings

HealthIMPACT Southeast (link is external) Tampa, FL January 23, 2015

Our other journal

P&T Journal for November 2014

Features

LETTER TO THE EDITOR

Medications for Parkinson’s Disease (link is external)

PERSPECTIVE

The Changing Roles of P&T Committees (link is external)

Epilepsy Management: Newer Agents, Unmet Needs, and Future Treatment Strategies (link is external)

PIPELINE PLUS

Modest Growth Seen in Epilepsy Market (link is external)

MEETING HIGHLIGHTS

European Society of Cardiology and Transcatheter Cardiovascular Therapeutics (link is external)

BOOK REVIEW

“Generic: The Unbranding of Modern Medicine,” by Jeremy A. Greene, MD, PhD (link is external)

DEPARTMENTSMEDICATION ERRORS

Misadministration of IV Insulin Associated With Dose Measurement And Hyperkalemia Treatment (link is external)

PRESCRIPTION: WASHINGTON

FDA’s Proposed 503B Draft Compounding Guidance Raises Concerns of All Kinds (link is external)

New Drugs/Drug News (link is external)

Pharmaceutical Approval Update (link is external)

DRUG FORECAST

Riociguat (Adempas): a Novel Agent For the Treatment of Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension (link is external)


Our most popular topics on Managedcaremag.com